Hoth Therapeutics, Inc. - COM NEW (HOTH)

CUSIP: 44148G204

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / COM NEW
Total 13F shares
243,673
Share change
-123,146
Total reported value
$182,285
Price per share
$0.75
Number of holders
14
Value change
-$112,479
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 44148G204?
CUSIP 44148G204 identifies HOTH - Hoth Therapeutics, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Hoth Therapeutics, Inc. - COM NEW (HOTH) as of Q4 2024

As of 31 Dec 2024, Hoth Therapeutics, Inc. - COM NEW (HOTH) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 243,673 shares. The largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, TWO SIGMA SECURITIES, LLC, UBS Group AG, Foundations Investment Advisors, LLC, TWO SIGMA INVESTMENTS, LP, MORGAN STANLEY, CITIGROUP INC, Tower Research Capital LLC (TRC), and SBI Securities Co., Ltd.. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.